Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 권휘안 | - |
dc.date.accessioned | 2022-03-11T07:07:29Z | - |
dc.date.available | 2022-03-11T07:07:29Z | - |
dc.date.issued | 2020-06 | - |
dc.identifier.citation | TRANSLATIONAL ANDROLOGY AND UROLOGY, v. 9, no. 3, page. 983-985 | en_US |
dc.identifier.issn | 2223-4683 | - |
dc.identifier.issn | 2223-4691 | - |
dc.identifier.uri | https://tau.amegroups.com/article/view/40828/html | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/169016 | - |
dc.description.abstract | Editorial Material | en_US |
dc.description.sponsorship | This study was supported by the Korean National Cancer Center (NCC1810866). | en_US |
dc.language.iso | en | en_US |
dc.publisher | AME PUBL CO | en_US |
dc.subject | CISPLATIN-INELIGIBLE PATIENTS | en_US |
dc.subject | SINGLE-ARM | en_US |
dc.subject | MULTICENTER | en_US |
dc.subject | CARCINOMA | en_US |
dc.subject | CHEMOTHERAPY | en_US |
dc.subject | PEMBROLIZUMAB | en_US |
dc.subject | ATEZOLIZUMAB | en_US |
dc.subject | GEMCITABINE | en_US |
dc.subject | PACLITAXEL | en_US |
dc.title | Optimizing frontline therapy in advanced urothelial cancer | en_US |
dc.type | Article | en_US |
dc.relation.no | 3 | - |
dc.relation.volume | 9 | - |
dc.identifier.doi | 10.21037/tau.2020.04.03 | - |
dc.relation.page | 983-985 | - |
dc.relation.journal | TRANSLATIONAL ANDROLOGY AND UROLOGY | - |
dc.contributor.googleauthor | Kwon, Whi-An | - |
dc.contributor.googleauthor | Seo, Ho Kyung | - |
dc.relation.code | 2020052424 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | kein917 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.